Molecular subtyping of head and neck cancer – Clinical applicability and correlations with morphological characteristics
Fabian Stögbauer(Technical University of Munich), Konrad Klinghammer(Charité - Universitätsmedizin Berlin), Wilko Weichert(Deutsches Konsortium für Translationale Krebsforschung), Ulrich Keller(Humboldt-Universität zu Berlin), Ingeborg Tinhofer(Klinik und Poliklinik für Strahlentherapie und Radioonkologie), Ulf Leser(Humboldt-Universität zu Berlin), Korinna Jöhrens(University Hospital Carl Gustav Carus), Ulrich Keilholz(German Cancer Research Center), Raik Otto(Humboldt-Universität zu Berlin), Christopher Poremba(Heinrich Heine University Düsseldorf), Melanie Boxberg(Starnberg Hospital)
Cited by 6
Related Papers
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial
|The Lancet|2008|644
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|621
Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
|The Oncologist|2011|579